Core Laboratories NV
NYSE:CLB

Watchlist Manager
Core Laboratories NV Logo
Core Laboratories NV
NYSE:CLB
Watchlist
Price: 21.66 USD 2.56%
Market Cap: 1B USD
Have any thoughts about
Core Laboratories NV?
Write Note

Intrinsic Value

The intrinsic value of one CLB stock under the Base Case scenario is 25.26 USD. Compared to the current market price of 21.66 USD, Core Laboratories NV is Undervalued by 14%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CLB Intrinsic Value
25.26 USD
Undervaluation 14%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Core Laboratories NV

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for CLB cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about CLB?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Core Laboratories NV

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Core Laboratories NV

Provide an overview of the primary business activities
of Core Laboratories NV.

What unique competitive advantages
does Core Laboratories NV hold over its rivals?

What risks and challenges
does Core Laboratories NV face in the near future?

Summarize the latest earnings call
of Core Laboratories NV.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Core Laboratories NV.

Provide P/S
for Core Laboratories NV.

Provide P/E
for Core Laboratories NV.

Provide P/OCF
for Core Laboratories NV.

Provide P/FCFE
for Core Laboratories NV.

Provide P/B
for Core Laboratories NV.

Provide EV/S
for Core Laboratories NV.

Provide EV/GP
for Core Laboratories NV.

Provide EV/EBITDA
for Core Laboratories NV.

Provide EV/EBIT
for Core Laboratories NV.

Provide EV/OCF
for Core Laboratories NV.

Provide EV/FCFF
for Core Laboratories NV.

Provide EV/IC
for Core Laboratories NV.

Show me price targets
for Core Laboratories NV made by professional analysts.

What are the Revenue projections
for Core Laboratories NV?

How accurate were the past Revenue estimates
for Core Laboratories NV?

What are the Net Income projections
for Core Laboratories NV?

How accurate were the past Net Income estimates
for Core Laboratories NV?

What are the EPS projections
for Core Laboratories NV?

How accurate were the past EPS estimates
for Core Laboratories NV?

What are the EBIT projections
for Core Laboratories NV?

How accurate were the past EBIT estimates
for Core Laboratories NV?

Compare the revenue forecasts
for Core Laboratories NV with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Core Laboratories NV and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Core Laboratories NV against its competitors.

Analyze the profit margins
(gross, operating, and net) of Core Laboratories NV compared to its peers.

Compare the P/E ratios
of Core Laboratories NV against its peers.

Discuss the investment returns and shareholder value creation
comparing Core Laboratories NV with its peers.

Analyze the financial leverage
of Core Laboratories NV compared to its main competitors.

Show all profitability ratios
for Core Laboratories NV.

Provide ROE
for Core Laboratories NV.

Provide ROA
for Core Laboratories NV.

Provide ROIC
for Core Laboratories NV.

Provide ROCE
for Core Laboratories NV.

Provide Gross Margin
for Core Laboratories NV.

Provide Operating Margin
for Core Laboratories NV.

Provide Net Margin
for Core Laboratories NV.

Provide FCF Margin
for Core Laboratories NV.

Show all solvency ratios
for Core Laboratories NV.

Provide D/E Ratio
for Core Laboratories NV.

Provide D/A Ratio
for Core Laboratories NV.

Provide Interest Coverage Ratio
for Core Laboratories NV.

Provide Altman Z-Score Ratio
for Core Laboratories NV.

Provide Quick Ratio
for Core Laboratories NV.

Provide Current Ratio
for Core Laboratories NV.

Provide Cash Ratio
for Core Laboratories NV.

What is the historical Revenue growth
over the last 5 years for Core Laboratories NV?

What is the historical Net Income growth
over the last 5 years for Core Laboratories NV?

What is the current Free Cash Flow
of Core Laboratories NV?

Discuss the annual earnings per share (EPS)
trend over the past five years for Core Laboratories NV.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Core Laboratories NV

Current Assets 223.1m
Cash & Short-Term Investments 15.1m
Receivables 123.1m
Other Current Assets 84.9m
Non-Current Assets 363.3m
PP&E 153.5m
Intangibles 106.4m
Other Non-Current Assets 103.4m
Current Liabilities 88.1m
Accounts Payable 33.5m
Accrued Liabilities 34.9m
Other Current Liabilities 19.7m
Non-Current Liabilities 273.5m
Long-Term Debt 163.1m
Other Non-Current Liabilities 110.3m
Efficiency

Earnings Waterfall
Core Laboratories NV

Revenue
509.8m USD
Cost of Revenue
-400m USD
Gross Profit
109.8m USD
Operating Expenses
-52.5m USD
Operating Income
57.4m USD
Other Expenses
-20.7m USD
Net Income
36.7m USD

Free Cash Flow Analysis
Core Laboratories NV

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

CLB Profitability Score
Profitability Due Diligence

Core Laboratories NV's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

50/100
Profitability
Score

Core Laboratories NV's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

CLB Solvency Score
Solvency Due Diligence

Core Laboratories NV's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
High Altman Z-Score
Low D/E
Long-Term Solvency
47/100
Solvency
Score

Core Laboratories NV's solvency score is 47/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CLB Price Targets Summary
Core Laboratories NV

Wall Street analysts forecast CLB stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLB is 19.67 USD with a low forecast of 14.14 USD and a high forecast of 25.2 USD.

Lowest
Price Target
14.14 USD
35% Downside
Average
Price Target
19.67 USD
9% Downside
Highest
Price Target
25.2 USD
16% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CLB?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for CLB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

CLB News

Other Videos

Profile

Core Laboratories NV Logo
Core Laboratories NV

Country

Netherlands

Industry

N/A

Market Cap

1B USD

Dividend Yield

0.18%

Description

Core Laboratories NV engages in the provision of proprietary and patented reservoir description, production enhancement, and reservoir management services to the oil and gas industry. The company is headquartered in Amstelveen, Noord-Holland and currently employs 3,700 full-time employees. The firm operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. The company provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. The company provides integrated diagnostic services to evaluate the effectiveness of well completions. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and recovery of oil and gas from its clients' reservoirs.

Contact

NOORD-HOLLAND
Amstelveen
Van Heuven Goedhartlaan 7 B
+31204203191.0
www.corelab.com

IPO

1998-07-10

Employees

3 700

Officers

Chairman of the Board, CEO, President & COO
Mr. Lawrence V. Bruno
Senior VP & CFO
Mr. Christopher Scott Hill
Senior Vice President of Corporate Development & Investor Relations
Ms. Gwendolyn Y. Gresham M.B.A.
Senior VP, Secretary & General Counsel
Mr. Mark Damian Tattoli
VP, Treasurer & Chief Accounting Officer
Mr. Sow Hang Teo
Vice President People, Organization, & Culture
Leslie Linklater
Show More
Managing Director
Mr. Jacobus Schouten
Senior VP of Production Enhancement & Business Development
J. Donald Dumas Jr.
Show Less

See Also

Discover More
What is the Intrinsic Value of one CLB stock?

The intrinsic value of one CLB stock under the Base Case scenario is 25.26 USD.

Is CLB stock undervalued or overvalued?

Compared to the current market price of 21.66 USD, Core Laboratories NV is Undervalued by 14%.

Back to Top